Health Equity and Rural Education (HERE!) Clinical Trial (HERE)

April 17, 2026 updated by: University of Kansas Medical Center

Health Equity and Rural Education (HERE!) Clinical Trial: A Healthcare-Community Partnership Leveraging School-Based Community Health Workers to Improve Student Attendance

The goal of this community-engaged research is two-fold. The first goal is to gather stakeholder feedback to inform a school-based community health worker intervention with youth with poor school attendance and an enhanced usual care condition. The second goal is to evaluate the feasibility of implementing the school-based community health worker intervention and enhanced usual care approach within rural schools.

The main question it aims to answer is whether it is feasibile to recruit children with poor school attendance and their families to the intervention, to complete the trauma-informed intervention, and to complete the associated study measures of meeting social determinants of health/mental health needs, school-based health center utilization, and behavioral helath symptoms. At least 38 rural students in grades 6-12 with poor school attendance and their parents/guardians will meet with the school-based community health worker for support around social determinants of health needs that may be barriers to attendance. Researchers will also assess the feasibility of recruiting at least 10 rural students and their parents/guardians to complete the study measures in an enhanced usual care condition in which the school-based health center without a school-based community health worker is reminded of the availability of an online social services directory.

Study Overview

Status

Recruiting

Conditions

Intervention / Treatment

Detailed Description

The HERE pilot study will consist of two phases to strengthen and finalize the HERE school-based community health worker (SB-CHW) intervention. The 6-month Phase I will provide broad stakeholder feedback on the proposed model and rationale, the SB-CHW intervention, the associated domains and measures, and the evaluation. The following 18-month Phase II will align with the school year and provide a feasibility test of the training, intervention, data collection, and analyses.

Study Type

Interventional

Enrollment (Estimated)

126

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Contact Backup

  • Name: Kelsey Dean
  • Phone Number: (816) 652-0065
  • Email: kdean@kumc.edu

Study Locations

  • United States
    • Kansas
      • Kansas City, Kansas, United States, 66160
        • Recruiting
        • University of Kansas Medical Center

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Child
  • Adult
  • Older Adult

Accepts Healthy Volunteers

Yes

Description

Phase I Stakeholder Interviews (nonintervention):

Inclusion Criteria:

  • A member of the program's Community Advisory Board, including community health workers;
  • Caregiver of a child ages 12-18 from the Southeast Kansas region; or
  • Student at least 12 years in age.

Phase II Feasibility Pilot- SB-CHW Intervention and Enhanced Usual Care Conditions

Inclusion Criteria:

  • Children ages 12-18 and their parents/guardians from the Southeast Kansas region
  • Student with or at risk for chronic poor attendance (missing 10% or more of the days that school has been in session at any point in the school year)

Exclusion Criteria:

  • Parents/guardians or youth with profound intellectual/cognitive disability will be excluded.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Non-Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
No Intervention: Study Phase I: Stakeholder Interviews
Phase I interviews with stakeholders (Community Advisory Board members, CHWs, community members, students Grade 6-12, & parent stakeholders) will be completed to inform the school-based community health worker and the enhanced usual care conditions in the Phase 2 feasibility pilot.
Experimental: Study Phase II: School-based Community Health Worker Intervention
The School-Based Community Health Worker (SB-CHW) intervention is the active intervention in the Phase II feasibility trial.
Behavioral: School-Based Community Health Worker (SB-CHW) intervention
The school-based community health worker will support students with chronic poor attendance and their parent/guardian for a minimum of two 30-minute encounters focused on addressing social determinants needs, understanding the range/student encounter varies greatly due to the intensity of the social need(s) (e.g., crisis/noncrisis) and the number of needs being jointly addressed. The SB-CHW will build relationships across encounters and apply trauma-informed best practices.
Active Comparator: Study Phase II: Enhanced Usual Care
Enhanced usual care (EUC) is the comparator in the Phase II feasibility trial.
Behavioral: Enhanced Usual Care (EUC) Methods
The network of school-based health centers without school-based community health workers will receive reminders of the the existing online social services directory.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
School Based Health Services Utilization
Time Frame: At study completion (an average of 10 months/1 school year)
The number of visits to School Based Health Centers (SBHC)
At study completion (an average of 10 months/1 school year)
School Attendance
Time Frame: At study completion (an average of 10 months/1 school year)

The number of school days in attendance, collected by ½ day increments

1(b) determination whether the student continues to meet the definition of chronic poor attendance (Yes/No)
At study completion (an average of 10 months/1 school year)

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Parent & Child Self-Sufficiency and Needs
Time Frame: At enrollment, at study completion (an average of 10 months/1 school year)
Arizona Self-Sufficiency Matrix. An 18-item self-report measure assessing needs on a 5-point Likert scale, including Housing, Employment, Income, Food, Childcare, Children's Education, Adult Education, Health Care Coverage, Life Skills, Family/Social Relations, Mobility, Community Involvement, Parenting Skills, Legal, Mental Health, Substance Abuse, Safety, and Disabilities.
At enrollment, at study completion (an average of 10 months/1 school year)
Child and Adolescent Needs and Strengths
Time Frame: At enrollment, at study completion (an average of 10 months/1 school year)
Child and Adolescent Needs and Strengths (CANS) is a validated semi-structured interview that assesses children's exposure to potentially traumatic experiences & level of traumatic stress symptoms, as well as considering strengths (Kisiel & Fehrenbach, 2015).
At enrollment, at study completion (an average of 10 months/1 school year)
Family Engagement
Time Frame: At enrollment, at study completion (an average of 10 months/1 school year)
The Family Engagement Survey -- Version 2 (FES), a validated measure of family and school engagement consisting of 20 items rated on a Likert-type scale from 1 (Strongly Disagree) to 5 (Strongly Agree).
At enrollment, at study completion (an average of 10 months/1 school year)
School-Based Community Health Worker Interactions
Time Frame: At study completion (an average of 10 months/1 school year)
Number of CHW interactions with the student, parent/guardian, and/or both
At study completion (an average of 10 months/1 school year)
Process for Enhanced Usual Care
Time Frame: At enrollment, at study completion (an average of 10 months/1 school year)
Use of resources from the online social services directory (yes/no)
At enrollment, at study completion (an average of 10 months/1 school year)

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

University of Kansas Medical Center

Collaborators

National Institute of Nursing Research (NINR)
National Institutes of Health (NIH)

Investigators

  • Principal Investigator: Eve-Lynn Nelson, PhD, University of Kansas Medical Center

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Estimated)

May 15, 2026

Primary Completion (Estimated)

December 1, 2026

Study Completion (Estimated)

December 31, 2026

Study Registration Dates

First Submitted

February 6, 2024

First Submitted That Met QC Criteria

June 10, 2024

First Posted (Actual)

June 14, 2024

Study Record Updates

Last Update Posted (Actual)

April 20, 2026

Last Update Submitted That Met QC Criteria

April 17, 2026

Last Verified

April 1, 2026

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • STUDY00151155
  • 1R56NR021161-01 (U.S. NIH Grant/Contract)

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

YES

IPD Plan Description

Public use and restricted access study data and associated documentation will be made available to the research community free of charge through the Data Sharing for Demographic Research (DSDR) data repository hosted at ICPSR. Datasets in DSDR will be findable and identifiable through a study digital object identifier (DOI) minted by ICPSR. Monitoring of and compliance with this Data Management and Sharing Plan will be the responsibility of the project's Principal Investigator and follow the data management and sharing plan compliance system through The Office of Sponsored Programs at the University of Kansas Medical Center that will be administering this award. The Office of Sponsored Programs will also look for the funder requirements and will include that information in the annual progress report.

IPD Sharing Time Frame

Final submission and release of the study data will occur approximately 6 months following the end of Phase 1 and Phase 2, respectively, and within the award period. Study data deposited in DSDR will be available to the research community in perpetuity. Datasets underlying methodological publications will be shared at or prior to initial publication date.

IPD Sharing Access Criteria

All deidentified study data that are not designated as restricted use will be made available as public use data to the research community via DSDR, with users of the public use data compliant with all Terms of Use. Data that are determined to be potentially identifying through indirect or deductive disclosure are provided under restricted data contract to users who demonstrate a valid research need and meet conditions of use. Access to restricted study data is available via a virtual data enclave system at DSDR/ICPSR.

IPD Sharing Supporting Information Type

  • STUDY_PROTOCOL
  • SAP
  • ICF
  • ANALYTIC_CODE
  • CSR

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Subscribe